menu
    • menu

    Company profile for Aurinia Pharmaceuticals

    NEW Drugs in Dev: 4
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aurinia is a clinical stage biopharmaceutical company focused on developing and commercializing therapies in disease areas of high unmet medical need. We are currently developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN) and focal segmental glomerularsclerosis (FSGS). Additionally, we are advancing voclosporin ophthalmic solution (VOS), a topical formulation, for the treatment of dry eye s...
    Aurinia is a clinical stage biopharmaceutical company focused on developing and commercializing therapies in disease areas of high unmet medical need. We are currently developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN) and focal segmental glomerularsclerosis (FSGS). Additionally, we are advancing voclosporin ophthalmic solution (VOS), a topical formulation, for the treatment of dry eye syndrome (DES). Our highly skilled leadership team has a proven track record of success. Together they possess more than 200 years of combined corporate and industry specific experience.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aurinia PharmaceuticalsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    #1203-4464 Markham Street Victoria, BC V8Z 7X8
    Telephone
    Telephone
    +1 (250) 744-2487
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.auriniapharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/aurinia-pharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/auriniapharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    LUPKYNIS Cuts Risk of Renal Event or Death by 53%
    LUPKYNIS Cuts Risk of Renal Event or Death by 53%

    04 Jun 2026

    // PRESS RELEASE

    https://www.auriniapharma.com/press-releases/lupkynis-associated-with-a-statistically-significant-53-reduction-in-risk-of-renal-related-event-or-death

    PRESS RELEASE
    04 Jun 2026
    Share Share
    Aurinia Pharmaceuticals Reports Q1 2026 Results & Progress Update
    Aurinia Pharmaceuticals Reports Q1 2026 Results & Progress Update

    07 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260507497614/en/Aurinia-Pharmaceuticals-Reports-Financial-Results-for-the-Three-Months-Ended-March-31-2026-and-Provides-Update-on-Recent-Business-Progress

    BUSINESSWIRE
    07 May 2026
    Share Share
    Tang Returns As Aurinia CEO With $50M Offer After Kezar Buyout
    Tang Returns As Aurinia CEO With $50M Offer After Kezar Buyout

    30 Mar 2026

    // BIOSPACE

    https://www.biospace.com/business/after-missing-kezar-buyout-in-2024-tang-returns-as-ceo-of-aurinia-with-50m-offer

    BIOSPACE
    30 Mar 2026
    Share Share
    Tang takes over Aurinia after FDA brouhaha—Chutes & Ladders
    Tang takes over Aurinia after FDA brouhaha—Chutes & Ladders

    27 Mar 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/chutes-ladders-tang-takes-over-aurinia-after-fda-brouhaha

    FIERCE BIOTECH
    27 Mar 2026
    Share Share
    Aurinia Announces Management Transition
    Aurinia Announces Management Transition

    23 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260323166862/en/Aurinia-Announces-Management-Transition

    BUSINESSWIRE
    23 Mar 2026
    Share Share
    Tang Assumes Aurinia CEO Role In Transformation C-Suite Overhaul
    Tang Assumes Aurinia CEO Role In Transformation C-Suite Overhaul

    23 Mar 2026

    // BIOSPACE

    https://www.biospace.com/business/tang-seizes-control-of-aurinia-taking-ceo-post-in-total-transformation-of-c-suite

    BIOSPACE
    23 Mar 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search